Emmanuel Maheu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Knee Osteoarthritis

Hyaluronic Acid

Top Venues

Journal of clinical medicine

Therapeutic advances in musculoskeletal disease

BMC musculoskeletal disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Migliore, Emmanuel Maheu, Luca Saccone, Gustavo C de Campos, Lyudmila Alekseeva, Xavier Chevalier, Thierry Conrozier, Sergio Crimaldi, Demirhan Diracoglu, Gabriel Herrero-Beaumont, Giovanni Iolascon, Ruxandra Ionescu, Jörg Jerosch, Jorge Lains, Souzi Makri, Natalia Martusevich, Marco Matucci Cerinic, Karel Pavelka, Robert J Petrella, Umberto Tarantino, Raveendhara R Bannuru
What We Should Expect from an Innovative Intra-Articular Hyaluronic Acid Product: Expert Opinion Based on a Comprehensive Review of the Literature. Journal of clinical medicine 12 (23) (2023)
Sitthiphong Suwannaphisit, Boonsin Tangtrakulwanich, Porames Suwanno, Nitiphoom Sinnathakorn, Emmanuel Maheu
Cross-cultural adaptation and validation of the Thai version of the functional index for hand osteoarthritis (FIHOA). BMC musculoskeletal disorders 23 (1) (2022)
Emmanuel Maheu, Sandrine Soriot-Thomas, Eric Noel, Hervé Ganry, Eric Lespessailles, Bernard Cortet
Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids. Therapeutic advances in musculoskeletal disease 14 (2022)
Alice Courties, Camille Deprouw, Emmanuel Maheu, Eric Gibert, Jacques-Eric Gottenberg, Julien Champey, Béatrice Banneville, Camille Chesnel, Gérard Amarenco, Alexandra Rousseau, Francis Berenbaum, Jérémie Sellam
Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial. Journal of clinical medicine 11 (4) (2022)
Emmanuel Maheu, Bernard Avouac, Renée Liliane Dreiser, Thomas Bardin
A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial. PloS one 14 (12) (2019)